Opportunity

DIBBS #SPE2DP-26-T-3152

DLA Solicitation for Moxifloxacin Hydrochloride Tablets (400 mg, 30-count)

Posted

April 29, 2026

Respond By

May 04, 2026

Identifier

SPE2DP-26-T-3152

NAICS

424210

The Defense Logistics Agency (DLA) Troop Support Medical Supply Chain Pharmacy FSA is soliciting bids for the supply of Moxifloxacin Hydrochloride Tablets for military use. - Government Buyer: - Defense Logistics Agency (DLA), Troop Support Medical Supply Chain Pharmacy FSA, Philadelphia, PA - Products Requested: - Moxifloxacin Hydrochloride Tablets, 400 mg, 30 tablets per bottle - NSN: 6505-01-503-4772 - Quantity: 3 bottles - Each bottle contains 30 tablets - Approved OEMs (Original Equipment Manufacturers): - TEVA PHARMACEUTICALS USA, INC. (NDC00093-7387-56) - DR REDDY'S LABORATORIES, INC. (NDC55111-0112-30) - RISING PHARMA HOLDINGS, INC. (NDC57237-0156-30) - Notable Requirements: - Delivery required within 20 days, FOB destination - Packaging and labeling must comply with Medical Marking Standard No. 1A and FDA regulations - Compliance with Buy American Act, Berry Amendment, and NIST SP 800-171 cybersecurity standards - Delivery Location: - USS Lewis B Puller ESB 3 (military vessel, FPO AE 09591) - Contracting Office: - DLA Troop Support Medical Supply Chain Pharmacy FSA, 700 Robbins Avenue, Philadelphia, PA 19111

Description

MOXIFLOXACIN HYDROC (QTY: 3, NSN: 6505-01-503-4772, Purchase Request: 7016539944) Approved Sources: - CAGE: 3V8D7, Part No: NDC00093-7387-56, Company: TEVA PHARMACEUTICALS USA, INC. - CAGE: 4E8M8, Part No: NDC55111-0112-30, Company: DR REDDY'S LABORATORIES, INC. - CAGE: 8FG82, Part No: NDC57237-0156-30, Company: RISING PHARMA HOLDINGS, INC.

View original listing